Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

38 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe.
Flaxman S, Mishra S, Gandy A, Unwin HJT, Mellan TA, Coupland H, Whittaker C, Zhu H, Berah T, Eaton JW, Monod M; Imperial College COVID-19 Response Team; Ghani AC, Donnelly CA, Riley S, Vollmer MAC, Ferguson NM, Okell LC, Bhatt S. Flaxman S, et al. Nature. 2020 Aug;584(7820):257-261. doi: 10.1038/s41586-020-2405-7. Epub 2020 Jun 8. Nature. 2020. PMID: 32512579
Risk factors for the spread of vaccine-derived type 2 polioviruses after global withdrawal of trivalent oral poliovirus vaccine and the effects of outbreak responses with monovalent vaccine: a retrospective analysis of surveillance data for 51 countries in Africa.
Cooper LV, Bandyopadhyay AS, Gumede N, Mach O, Mkanda P, Ndoutabé M, Okiror SO, Ramirez-Gonzalez A, Touray K, Wanyoike S, Grassly NC, Blake IM. Cooper LV, et al. Lancet Infect Dis. 2022 Feb;22(2):284-294. doi: 10.1016/S1473-3099(21)00453-9. Epub 2021 Oct 11. Lancet Infect Dis. 2022. PMID: 34648733 Free PMC article.
Use of inactivated poliovirus vaccine for poliovirus outbreak response.
Bandyopadhyay AS, Lopez Cavestany R, Blake IM, Macklin G, Cooper L, Grassly N, Nery ALMDS, Mach O. Bandyopadhyay AS, et al. Lancet Infect Dis. 2024 May;24(5):e328-e342. doi: 10.1016/S1473-3099(23)00505-4. Epub 2023 Nov 25. Lancet Infect Dis. 2024. PMID: 38012892 Review.
Effectiveness of poliovirus vaccines against circulating vaccine-derived type 2 poliomyelitis in Nigeria between 2017 and 2022: a case-control study.
Cooper LV, Erbeto TB, Danzomo AA, Abdullahi HW, Boateng K, Adamu US, Shuaib F, Modjirom N, Gray EJ, Bandyopadhyay AS, Zipursky S, Okiror SO, Grassly NC, Blake IM. Cooper LV, et al. Lancet Infect Dis. 2024 Apr;24(4):427-436. doi: 10.1016/S1473-3099(23)00688-6. Epub 2024 Jan 18. Lancet Infect Dis. 2024. PMID: 38246190 Free article.
38 results